Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Armata Pharmaceuticals, Inc.

NYSE: ARMP · Life Sciences · 4 alerts · CIK 921114

Share price
$2.99Close, Nov 16
Market cap
$111M
Shares outstanding
37.19MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Armata Pharmaceuticals, Inc. filings on SEC EDGAR ↗

7:11 AM ET 8-K
Business Update

Armata Pharmaceuticals Business Update

Armata Pharmaceuticals received $3.7 million in additional non-dilutive funding from the U.S. Department of War to support the Phase 3 development of its AP-SA02 bacteriophage candidate. This incremental funding brings the total cumulative government support for the program to $32.4 million and is intended to fund activities for a pivotal superiority study in complicated S. aureus bacteremia.

Counterparty
U.S. Department of War

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.